ArticleTransplantation direct2026
Thirty Years and Beyond: Long-term Outcomes After Liver Transplantation at a Single Center: Progress, Challenges, and Future Implications.
Article in Transplantation direct, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The liver transplantation (LT) program was established at Hannover Medical School in 1972. The aim of the study was to assess graft and patient survival, organ function, and active life throughout ≥3 decades after LT, with a special focus on recipients surviving ≥30 y after transplantation. Methods: Clinical data from all consecutive patients undergoing LT between 1972 and 1994 were collected in a prospective design, and outcome data were complemented retrospectively. Results: Nine hundred LTs performed on 756 patients were included in the study. Survival increased with growing experience during the study period. One hundred thirty-eight patients survived ≥30 y, of whom 35 (25%) received >1 graft. Chronic kidney disease was observed in 96 recipients (70%), necessitating additional kidney transplants in 16 patients (12%). De novo malignancy was diagnosed in 31 patients (23%; 4% after pediatric and 33% after adult LT, Conclusions: This is the first study offering detailed insight into LT survival beyond 30 y. The data show that 30-y survival after LT is reachable in relevant numbers, with stable graft function and the opportunity to live an active, self-directed life.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.